Synlogic, Inc. (LON:0A8U)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 6.45M -36.9% |
| Revenue (ttm) | n/a |
| Net Income | -485.43K |
| EPS | -0.05 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Open | 0.6050 |
| Previous Close | n/a |
| Day's Range | 0.6050 - 0.6050 |
| 52-Week Range | 0.5401 - 1.9250 |
| Beta | 0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |
About Synlogic
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts. [Read more]
News
Synlogic Quarterly report: Q1 2026
Synlogic has published its Q1 2026 quarterly earnings report on May 14, 2026.
Synlogic Annual report: Q4 2025
Synlogic has published its Q4 2025 annual report on March 12, 2026.
Synlogic Quarterly report: Q3 2025
Synlogic has published its Q3 2025 quarterly earnings report on November 13, 2025.
Synlogic Proxy statement: Proxy Filing
Synlogic filed a proxy statement on November 12, 2025, providing details for shareholder voting and corporate governance matters.
Synlogic Registration statement: Registration Filing
Synlogic filed a registration statement on August 15, 2025, providing details about a securities offering with the SEC.
Synlogic files $150M mixed securities shelf
16:01 EDT Synlogic (SYBX) files $150M mixed securities shelf
Synlogic Registration statement: Registration Filing
Synlogic filed a registration statement on August 8, 2025, providing details about a securities offering with the SEC.
Synlogic Quarterly report: Q2 2025
Synlogic has published its Q2 2025 quarterly earnings report on August 7, 2025.
Synlogic Quarterly report: Q1 2025
Synlogic has published its Q1 2025 quarterly earnings report on May 7, 2025.
Synlogic Annual report: Q4 2024
Synlogic has published its Q4 2024 annual report on March 6, 2025.
Synlogic Reports Third Quarter 2024 Financial Results
WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported f...
Synlogic Quarterly report: Q3 2024
Synlogic has published its Q3 2024 quarterly earnings report on November 12, 2024.
Synlogic Earnings release: Q3 2024
Synlogic released its Q3 2024 earnings on November 12, 2024, summarizing the period's financial results.
Synlogic Proxy statement: Proxy Filing
Synlogic filed a proxy statement on November 6, 2024, providing details for shareholder voting and corporate governance matters.
Synlogic reports Q2 EPS 16c vs ($3.21) last year
Reports Q2 revenue $0 vs $35,000 last year
Synlogic Quarterly report: Q2 2024
Synlogic has published its Q2 2024 quarterly earnings report on August 8, 2024.
Synlogic Earnings release: Q2 2024
Synlogic released its Q2 2024 earnings on August 8, 2024, summarizing the period's financial results.
Synlogic Reports Second Quarter 2024 Financial Results
WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported f...
Synlogic Reports First Quarter 2024 Financial Results
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported fin...
Synlogic Quarterly report: Q1 2024
Synlogic has published its Q1 2024 quarterly earnings report on May 14, 2024.
Synlogic Earnings release: Q1 2024
Synlogic released its Q1 2024 earnings on May 14, 2024, summarizing the period's financial results.
Synlogic upgraded to Neutral from Sell at H.C. Wainwright
H.C. Wainwright upgraded Synlogic to Neutral from Sell.
Synlogic reports Q4 EPS ($1.71), consensus (97c)
Reports Q4 revenue $2.77M, consensus $2.73M.
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported f...
Synlogic Earnings release: Q4 2023
Synlogic released its Q4 2023 earnings on March 19, 2024, summarizing the period's financial results.